Targeting Glioblastoma: Efficacy of Ruthenium-Based Drugs
Ruthenium compounds offer improved selectivity and fewer side effects compared to platinum-based drugs in glioblastoma treatment. Insights into their interactions with transferrin suggest targeted drug delivery, while photoactivated chemotherapy is a novel cytotoxic approach in tumor tissues.
Authors
- Puthiyavalappil Rasin
- Jebiti Haribabu (ORCID: https://orcid.org/0000-0001-8855-032X)
- Anandaram Sreekanth (ORCID: https://orcid.org/0000-0002-2942-8487)
- Sravan Sangeeth Surendran (ORCID: https://orcid.org/0009-0007-2495-0026)
- Kotikalapudi Sreeramachandra Karthik
Institutions
- National Institute of Technology Tiruchirappalli (IN)
- University of Atacama (CL)
Publication Details
- Journal
- Chemical Research in Toxicology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1021/acs.chemrestox.4c00188
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Education, India
- Universidad de Atacama